Zydus Wellness (531335) Q4 05/06 earnings summary
Event summary combining transcript, slides, and related documents.
Q4 05/06 earnings summary
3 Nov, 2026Executive summary
Sales and other income rose 9.12% to Rs. 315.47 crore in FY06, while net profit edged down to Rs. 2.48 crore from Rs. 2.49 crore.
Nutralite margarine remained the core product, positioned as a cholesterol-free butter substitute; control changed after Cadila Healthcare acquired 61.56% of the shares.
Financial highlights
Sales and other income were Rs. 315.47 crore versus Rs. 289.10 crore in FY05; reported growth was 9.12%.
PBT was Rs. 4.77 crore versus Rs. 3.93 crore; PAT was Rs. 2.48 crore versus Rs. 2.49 crore.
EPS fell to Rs. 4.45 from Rs. 5.33; proposed dividend was 10%, or Re. 1 per equity share.
Outlook and guidance
Management saw opportunity in rising health awareness and demand for healthier butter substitutes, and aimed to provide healthier products.
Management expected to address vegetable-oil price volatility through strategic planning; actual results could differ from forward-looking expectations.
Latest events from Zydus Wellness
- Sales and EBITDA surged as gross margin expanded and brand growth continued.531335
Q2 26/27 - Sales rose, but FY98 ended with a Rs. 78.8 lakh net loss.531335Q4 97/98
- Revenue rose 42%, profit after tax doubled, and a Rs. 0.60/share dividend was proposed.531335Q4 02/03
- Sales surged, but FY99 ended with a Rs 45,36,571 loss before tax.531335Q4 98/99
- Higher sales and production accompanied a narrower loss, but operating cash flow remained negative.531335Q4 99/00
- FY02 profit improved as new-product investment positioned the business for growth.531335Q4 01/02
- Sales more than doubled as profits rose and product expansion broadened.531335Q4 03/04
- Revenue rose 60.75% as capacity expansion and regional growth plans advanced.531335Q4 04/05
- Revenue surged 49%, but profit eased amid advertising investment; Nutralite Premium launched.531335Q4 06/07